Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)

This Funding Opportunity Announcement (FOA) invites applications for support of pre-clinical studies to repurpose existing experimental or FDA approved drugs or biologics (existing therapeutics) that have already begun or completed at least a Phase l trial.

The hypothesis for proposed studies

credit:


must be developed using innovative processes to identify the therapeutic/indication pair.

Examples include independent crowdsourcing strategies (e.g., http://www.ncats.nih.gov/ntu/assets/current, http://openinnovation.astrazeneca.com/, or any website that lists experimental therapies), or use of computational algorithms.

The initial UG3 award will support the development of milestone-driven rigorous, pre-clinical target engagement and/or efficacy studies.

Once UG3 pre-clinical milestones have been met, the UH3 award may be made to support clinical trial planning:
this includes complete planning, design, and preparation of the documentation necessary for implementation of Phase I and/or Phase II clinical trials for a new therapeutic use.
Related Programs

National Center for Advancing Translational Sciences

Department of Health and Human Services


Agency: National Institutes of Health

Office:

Estimated Funding: $1,542,548


Who's Eligible



Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-465.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Full Opportunity Web Address:


Contact:


Agency Email Description:


Agency Email:
FBOWebmaster@OD.NIH.GOV

Date Posted:
2017-08-21

Application Due Date:
2020-09-07

Archive Date:
2020-10-13


Here, five companies are marking their imprints to implement their corporate philanthropy goals. These companies are: Patagonia, Fuse Corps, Dow Corning, Warner Bros., and VeryNice.




Nonprofit Jobs in Arkansas

  Fundraising & Development Jobs
  Education Jobs
  Human Services Jobs
  Social Work Jobs
  Program Director Jobs





More Federal Domestic Assistance Programs


Nurse Anesthetist Traineeship | Comprehensive Centers | Promoting Readiness of Minors in Supplemental Security Income | Incentive Grant Program to Increase Motorcyclist Safety | Title II, Colorado River Basin Salinity Control  |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2021 Copyright Michael Saunders